Mark Mehler

Prof. Mark Mehler


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2012 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
IQIrfan Qureshi
Irfan Qureshi
MMMark Mehler
Mark Mehler

1 June 2010 in Brain Research
Verified
Journal Article
Closed access
IQIrfan A. Qureshi
Irfan A. Qureshi
JMJohn Mattick
John Mattick
MMMark Mehler
Mark Mehler

1 July 2012 in Developmental Biology
Verified
Journal Article
Closed access
SNSayan Nandi
Sayan Nandi
SGSolen Gokhan
Solen Gokhan
XDXu-Ming Dai
Xu-Ming Dai
SWSuwen Wei
Suwen Wei
GEGrigori Enikolopov
Grigori Enikolopov
ESE. Richard Stanley
E. Richard Stanley

15 November 2010 in Cell Cycle
Verified
Journal Article
Open access
PDF file
IQIrfan A. Qureshi
Irfan A. Qureshi
SGSolen Gokhan
Solen Gokhan
MMMark Mehler
Mark Mehler
Complementary transcriptional and epigenetic regulatory factors (e.g., histone and chromatin modifying enzymes and non-coding RNAs) regulate genes responsible for mediating neural stem cell maintenance and lineage restriction, neuronal and glial lineage specification, and progressive stages of lineage maturation. However, an overall understanding of the mechanisms that sense and integrate developmental signals at the genomic level and control cell type-specific gene network deployment has not emerged. REST and CoREST are central players in the transcriptional and epigenetic regulatory circuitry that is responsible for modulating neural genes, and they have been implicated in establishing cell identity and function, both within the nervous system and beyond it. Herein, we discuss the emerging context-specific roles of REST and CoREST and highlight our recent studies aimed at elucidating their neural developmental cell type- and stage-specific actions. These observations support the conclusion that REST and CoREST act as master regulators of key neural cell fate decisions.

2 May 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AMAldrin E. Molero
Aldrin E. Molero
EAEduardo E. Arteaga-Bracho
Eduardo E. Arteaga-Bracho
CCChristopher H. Chen
Christopher H. Chen
MGMaria Gulinello
Maria Gulinello
MWMichael L. Winchester
Michael L. Winchester
MMMark Mehler
Mark Mehler
Recent studies have identified impairments in neural induction and in striatal and cortical neurogenesis in Huntington’s disease (HD) knock-in mouse models and associated embryonic stem cell lines. However, the potential role of these developmental alterations for HD pathogenesis and progression is currently unknown. To address this issue, we used BACHD:CAG-CreERT2 mice, which carry mutant huntingtin (mHtt) modified to harbor a floxed exon 1 containing the pathogenic polyglutamine expansion (Q97). Upon tamoxifen administration at postnatal day 21, the floxed mHtt-exon1 was removed and mHtt expression was terminated (Q97CRE). These conditional mice displayed similar profiles of impairments to those mice expressing mHtt throughout life: (i) striatal neurodegeneration, (ii) early vulnerability to NMDA-mediated excitotoxicity, (iii) impairments in motor coordination, (iv) temporally distinct abnormalities in striatal electrophysiological activity, and (v) altered corticostriatal functional connectivity and plasticity. These findings strongly suggest that developmental aberrations may play important roles in HD pathogenesis and progression.

1 October 2013 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
IQIrfan A. Qureshi
Irfan A. Qureshi
MMMark Mehler
Mark Mehler